Dawn Health builds patient-facing apps, digital therapies and software-as-a-medical-device aimed at chronic disease care and works with international life-science and pharmaceutical partners. The company says its solutions are used across multiple international markets and it aims to be a global technology partner that bridges technology, patient experience and regulatory requirements. The new financing is intended to scale its platform and expand its product portfolio to enable faster cross-market deployments. Dawn Health is increasing investments in staff and development, which contributed to rising costs. In its most recent fiscal year the company reported a loss of DKK 52.2 million versus a DKK 25.3 million loss the prior year.

Total raised

$77M

Funding rounds

4

Latest round

Equity

Latest activity

Jun 2026